Literature DB >> 3040193

Brain spectrin, calpain and long-term changes in synaptic efficacy.

G Lynch, M Baudry.   

Abstract

This chapter discusses the possibility that proteolytic digestion of cytoskeletal proteins, in particular spectrin, is part of the mechanisms through which physiological activity elicits structural and chemical changes in brain synapses. Recent work from several laboratories has produced a description of the initial events that trigger the long-term potentiation (LTP) of synaptic responses that appears in hippocampus after brief episodes of high frequency electrical stimulation. A likely sequence is as follows: suppression of IPSPs, prolongation of EPSPs, activation of N-methyl-D-aspartate (NMDA) receptors, influx of calcium into target cells. After briefly describing the evidence for this triggering sequence, the review takes up the question of what types of calcium sensitive chemistries are available to synaptic region that could produce functional changes lasting for weeks (i.e., for LTP). It is argued that the partial degradation of spectrin by a calcium-activated protease (calpain) provides a mechanism of this type. Spectrin is a substrate for calpain and both it and a breakdown product comparable to that produced by calpain are found in postsynaptic densities. Moreover, there is substantial evidence that spectrin regulates the surface chemistry and morphology of cells and thus its partial degradation would be expected to produce pronounced and persistent modifications in synapses. To reinforce this point, the review discusses recent findings suggesting that calpain mediated proteolysis of spectrin and other cytoskeletal proteins produces substantial changes in the shape of blood-borne cells and the distribution of their surface receptors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040193     DOI: 10.1016/0361-9230(87)90220-6

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  30 in total

1.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

Review 2.  Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.

Authors:  Michel Baudry; Xiaoning Bi
Journal:  Trends Neurosci       Date:  2016-02-10       Impact factor: 13.837

3.  Long-term potentiation in the hippocampus in conditions of inhibition of caspase-3: analysis of facilitation in paired-pulse stimulation.

Authors:  I V Kudryashova; I E Kudryashov; N V Gulyaeva
Journal:  Neurosci Behav Physiol       Date:  2006-10

4.  Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1alpha truncation.

Authors:  Miou Zhou; Wei Xu; Guanghong Liao; Xiaoning Bi; Michel Baudry
Journal:  Exp Neurol       Date:  2009-04-15       Impact factor: 5.330

5.  Developmental changes of calpain and calpastatin in rabbit brain.

Authors:  K Blomgren; J O Karlsson
Journal:  Neurochem Res       Date:  1989-11       Impact factor: 3.996

6.  Ischemic preconditioning attenuates of ischemia-induced degradation of spectrin and tau: implications for ischemic tolerance.

Authors:  Takayuki Nakajima; Syoichi Ochi; Chika Oda; Maki Ishii; Kazushige Ogawa
Journal:  Neurol Sci       Date:  2010-07-02       Impact factor: 3.307

7.  Calcium-activated proteases are critical for refilling depleted vesicle stores in cultured sensory-motor synapses of Aplysia.

Authors:  Arkady Khoutorsky; Micha E Spira
Journal:  Learn Mem       Date:  2005 Jul-Aug       Impact factor: 2.460

8.  Modulation of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/quisqualate receptors by phospholipase A2: a necessary step in long-term potentiation?

Authors:  G Massicotte; P Vanderklish; G Lynch; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

9.  Spectrin Breakdown Products (SBDPs) as Potential Biomarkers for Neurodegenerative Diseases.

Authors:  Xiao-Xin Yan; Andreas Jeromin; A Jeromin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-06

10.  Semaphorin 5B mediates synapse elimination in hippocampal neurons.

Authors:  Timothy P O'Connor; Katie Cockburn; Wenyan Wang; Lucia Tapia; Erin Currie; Shernaz X Bamji
Journal:  Neural Dev       Date:  2009-05-23       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.